Prolonged Nightly Fasting in Fibromyalgia
Reason given: Study discontinued due to unexpected funding constraints and resource limitations.
Key facts
- Where
- Phoenix, United StatesSee the site
Where in United States
- Arizona State UniversityPhoenix, United StatesNo longer taking part
Trial details
- Who runs it
- Arizona State University
- Trial code
- NCT05581849
- Record updated
- 6 April 2025
- Original description
The present randomized-controlled pilot trial will test the feasibility, acceptability, and preliminary efficacy of an 8-week prolonged nightly fasting (PNF) intervention protocol in 20 adults with fibromyalgia.Read full original descriptionShow less
Prolonged Nightly Fasting in Individuals With Fibromyalgia: A Pilot Study
The present randomized-controlled pilot trial will test the feasibility, acceptability, and preliminary efficacy of an 8-week prolonged nightly fasting (PNF) intervention protocol in 20 adults with fibromyalgia.
Aim 1: Evaluate feasibility and acceptability of the PNF intervention among participants with fibromyalgia.
Aim 2: Evaluate preliminary efficacy of PNF on pain severity and sensitivity, mood, sleep and inflammation.
Inclusion: age between 18 and 65; female; able to speak, write, and read English; classified as having fibromyalgia based upon criteria established by the most up-to-date 2016 American College of Rheumatology (ACR) Criteria for Fibromyalgia; has a smartphone.
Exclusion: current use of melatonin or an immunosuppressant medication (e.g., steroids); history of eating disorders assessed by MINI Neuropsychiatric Interview; self-report of chronic malignant pain (e.g., cancer, HIV) or systemic inflammatory disease (e.g., rheumatoid arthritis, ankylosing spondylitis, lupus); has diabetes mellitus; currently pregnant, trying to get pregnant, or breastfeeding; plans to relocate within the next 6 months; currently trying to lose weight; currently routinely fasting more than 12 hours a night; works night shifts.